Tender Title: Tab Nubeqa (Darolutamide) 300 mg

Reference Number: GEM/2025/B/6103509

The Department of Defence under the Ministry of Defence is inviting bids for the procurement of Tab Nubeqa (Darolutamide) 300 mg. This tender aims to secure a total quantity of 360 units of the specified medication to ensure continued support for defense personnel health.

Scope of Work and Objectives

The primary objective of this tender is to facilitate the acquisition of Tab Nubeqa, which is critical in the treatment of specific medical conditions. Suppliers are expected to provide high-quality products adhering to the specifications outlined in the tender documents. The scope of work includes timely delivery of the medication to designated locations as determined by the Department of Defence.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet the following eligibility criteria:

• Must be a registered entity with relevant authorities.
• Experience in supplying pharmaceutical products to government agencies is highly desirable.
• Compliance with all applicable local laws and regulations regarding healthcare supplies.

Technical Requirements

Bidders must provide documentation demonstrating their adherence to the technical requirements of the Tab Nubeqa (Darolutamide), including:

• Certificates of analysis and compliance with international quality standards.
• Product specifications and packaging details.
• Evidence of prior supply contracts involving similar pharmaceutical products.

Financial Requirements

Bidders are required to submit their financial proposals, including:

• Pricing per unit of Tab Nubeqa (Darolutamide) 300 mg.
• Overall cost for the total quantity of 360 units.
• Any applicable taxes and duties must be clearly indicated in the proposal.

Document Submission Details

Interested participants are required to submit their bids electronically. All proposals must include:

• Completed bidding forms available through the designated electronic portal.
• All relevant certifications and documentation in support of eligibility and technical compliance.
• A comprehensive financial breakdown.

Special Provisions

This tender includes special provisions for Micro, Small, and Medium Enterprises (MSEs) and startups, encouraging their participation in supplying pharmaceutical products. This is part of a broader commitment to fostering local businesses and promoting economic growth within the healthcare supply sector.

Evaluation Process

The evaluation process will consist of a thorough assessment of the bids based on:

• Compliance with technical specifications.
• Financial viability and competitiveness of pricing.
• Track record and capability of the bidder to meet delivery schedules.

Delivery Locations

Successful bidders will be required to deliver the medication to the specific locations identified by the Department of Defence. Additional delivery instructions will be provided to the winning bidder at the time of contract issuance.

Contact Information

For any inquiries, participants are encouraged to reach out to the designated contact at the Department of Defence, ensuring all communication is conducted through official channels.

In conclusion, this tender represents an essential opportunity for registered pharmaceutical suppliers to engage with the Department of Defence, providing valuable medication to ensure the health and well-being of defense personnel.